Flex Pharma

πŸ“ Boston, United StatesπŸ—“ Founded 2014πŸ‘₯ 7 employeesπŸ’° Last funded Sep 2015
Our Company: Novel Treatments for Neuromuscular Disorders. Flex Pharma is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, and has demonstrated human efficacy related to muscle cramping. Novel Treatments for Neuromuscular Disorders, including Muscle Cramps. There is currently no proven or effective product for muscle cramps and spasms. Most muscle cramps are not caused by dehydration, lactic acid, electrolyte imbalance, or muscle tightness. That is why popular remedies like sports drinks, bananas, magnesium tablets, and stretching are usually ineffective. New research has shown that cramps and spasms do not originate in the muscle itself, but are caused instead by a neural mechanism: excessive firing of the motor neurons in the spinal cord that control muscle contraction. Flex Pharma is developing products to address muscle cramps and spasms by halting repetitive firing of the motor neurons. Our founders include professors from Harvard Medical School and Rockefeller University (Nobel prize, 2003). Preliminary testing of Flex Pharma’s product in humans has shown that it can relieve electrically induced muscle cramps in minutes, and the effect lasts for hours.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Flex Pharma?
Flex Pharma has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Flex Pharma last raise funding?
The most recent investment in Flex Pharma recorded on gritt.io was in September 2015.
When was Flex Pharma founded?
Flex Pharma was founded in 2014.
What industry is Flex Pharma in?
Flex Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Flex Pharma based?
Flex Pharma is headquartered in Boston, United States.